PG
BMY icon

PEAK6 Group’s Bristol-Myers Squibb BMY Stock Holding History

PEAK6 Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$7.38M Sell
133,400
-42,300
-24% -$2.28M 0.03% 588
2018
Q1 		$11.1M Buy
175,700
+67,400
+62% +$4.34M 0.05% 410
2017
Q4 		$6.64M Sell
108,300
-618,000
-85% -$38.7M 0.03% 674
2017
Q3 		$46.3M Buy
726,300
+371,400
+105% +$21.7M 0.24% 64
2017
Q2 		$19.8M Buy
354,900
+188,800
+114% +$10.3M 0.11% 160
2017
Q1 		$9.03M Buy
166,100
+129,500
+354% +$7.1M 0.07% 319
2016
Q4 		$2.14M Sell
36,600
-112,300
-75% -$6.14M 0.02% 1258
2016
Q3 		$8.03M Buy
148,900
+50,500
+51% +$3.24M 0.06% 450
2016
Q2 		$7.24M Buy
98,400
+52,100
+113% +$3.68M 0.06% 486
2016
Q1 		$2.96M Sell
46,300
-225,200
-83% -$14.2M 0.02% 916
2015
Q4 		$18.7M Buy
271,500
+37,500
+16% +$2.48M 0.13% 170
2015
Q3 		$13.9M Sell
234,000
-160,800
-41% -$10.2M 0.07% 339
2015
Q2 		$26.3M Buy
394,800
+89,800
+29% +$5.92M 0.16% 118
2015
Q1 		$19.7M Buy
305,000
+248,600
+441% +$15.6M 0.15% 122
2014
Q4 		$3.33M Sell
56,400
-65,000
-54% -$3.67M 0.03% 911
2014
Q3 		$6.21M Buy
121,400
+91,000
+299% +$4.55M 0.05% 526
2014
Q2 		$1.48M Sell
30,400
-76,000
-71% -$3.75M 0.01% 1309
2014
Q1 		$5.53M Buy
106,400
+104,400
+5,220% +$5.56M 0.05% 568
2013
Q4 		$106K Sell
2,000
-76,900
-97% -$3.92M ﹤0.01% 3973
2013
Q3 		$3.65M Buy
78,900
+68,900
+689% +$3.02M 0.03% 1040
2013
Q2 		$447K Buy
+10,000
New +$434K ﹤0.01% 2901

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PEAK6 Group's BMY Position: Q2 2018 in Review

PEAK6 Group increased its Bristol-Myers Squibb (BMY) stake by 66% in Q2 2018, buying an estimated $1.78M and bringing the position to 82,852 shares worth $4.58M. The position accounts for 0.02% of the portfolio, ranked #818.

PEAK6 Group first reported a position in BMY in Q3 2013 and has held it in 12 quarters since. The position peaked at $12.1M in Q4 2016. 1,691 funds tracked by Wall St. Rank hold BMY as of Q2 2018.

  • PEAK6 Group held 82,852 shares of Bristol-Myers Squibb worth $4.58M as of Q2 2018.
  • PEAK6 Group bought 32,903 Bristol-Myers Squibb shares in Q2 2018, an estimated $1.78M.
  • Bristol-Myers Squibb made up 0.02% of PEAK6 Group's portfolio in Q2 2018, its #818 holding.
  • PEAK6 Group first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 12 quarters since.
  • PEAK6 Group's Bristol-Myers Squibb position peaked at $12.1M in Q4 2016.
  • 1,691 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.